多功能红素载入脂质体:为增强粘膜粘合,抗氧化活性和生物相容性进行方法优化
Vera-Maria Platon1, Anda Mihaela Craciun1, Irina Rosca1
1"Petru Poni" Institute of Macromolecular Chemistry, Aleea Gr. Ghica Voda 41A, Iasi 700487, Romania. lmarin@icmpp.ro.
Biomaterials science
|September 23, 2025
概括
被基托寡合体 (CSO) 覆盖的优化红色素载荷脂质体 (ERY-脂质体) 显示出增强的抗菌活性和粘膜粘合. 这些纳米载体为抗生素耐药性提供了改善的药物输送.
科学领域:
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脂质体是抗菌剂的先进纳米载体,改善药物的药理动力学,以对抗抗生素耐药性.
- 红红素 (ERY) 是一种关键的抗生素,但为了更好的疗效,可以提高其输送效率.
- 酸盐寡合物 (CSO) 提供粘膜粘合剂,抗氧化剂和抗微生物特性,有利于药物输送系统.
研究的目的:
- 系统地优化被基托寡合体 (CSO) 覆盖的红色素载荷脂质体 (ERY-脂质体).
- 为了实现纳米级药物封装,增强粘膜,抗氧化剂,抗微生物和生物相容性属性.
- 评估优化ERY脂质体的物理化学,结构,释放和生物特性.
主要方法:
- 多变量分析用于优化关键配方参数 (脂质与药物比率,薄膜形成,水化,缩小,CSO特性,冷保护剂).
- 使用FTIR,1H-NMR,DLS,STEM,AFM,XRD和POM进行全面的物理化学和结构特征.
- 在体外评估药物释放动力学,抗菌活性,抗氧化能力,粘膜粘合和细胞相容性.
主要成果:
- 优化的ERY脂质体表现出63%的封装效率,97纳米大小和低PDI (<0.1).
- 结构分析证实药物在无形状态中被纳入密集的囊泡中,具有粗的CSO涂层.
- 配方显示持续的ERY释放,强大的24小时抗菌活性,显著的抗氧化作用 (80%的激素抑制),粘膜粘合和纤维细胞细胞相容性.
结论:
- 优化的ERY-脂质体显示出作为先进的红素输送纳米载体的显著潜力.
- 该配方结合了增强的药物封装,受控释放,强大的抗菌作用和有益的生物特性.
- 这些发现支持ERY脂质体在治疗细菌感染和抗生素耐药性的治疗应用.
相关概念视频
01:27Bioavailability Enhancement: Drug Permeability Enhancement
188
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
188
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
01:16Bioavailability Enhancement: Drug Solubility Enhancement
223
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
223
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
507
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
507